my fitness deteriorated significantly after 2nd; after 2nd would hit 130pbm walking up my stairs at home; postural orthostatic tachycardia syndrome/diagnosed with pots in nov2021; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. the reporter is the patient. other case identifier(s): gb-mhra-vac-202202120809137090-avbvp, gb-mhra-adr 26597486. a 38 year-old male patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "drug hypersensitivity" (unknown if ongoing); "i must have had covid" (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation, reaction(s): "fitness deteriorated slightly". the following information was reported: postural orthostatic tachycardia syndrome (disability, medically significant) with onset nov2021, outcome "not recovered", described as "postural orthostatic tachycardia syndrome/diagnosed with pots in nov2021"; general physical health deterioration (disability, medically significant), outcome "unknown", described as "my fitness deteriorated significantly after 2nd"; heart rate increased (disability, medically significant), outcome "unknown", described as "after 2nd would hit 130pbm walking up my stairs at home". the patient underwent the following laboratory tests and procedures: heart rate: 130 bpm; 110 bpm. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200308268 same patient/drug and different dose/events

test name: heart rate; result unstructured data: test result:130 bpm; test name: heart rate; result unstructured data: test result:110 bpm

na

na